Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands?

Suppr

超能文献

作者信息

Soerjomataram Isabelle, Coebergh Jan Willem, Louwman Marieke W J, Visser Otto, van Leeuwen Flora E

出版信息

J Clin Oncol. 2007 Nov 1;25(31):5038-9; author reply 5039-40. doi: 10.1200/JCO.2007.13.7281.

DOI:10.1200/JCO.2007.13.7281

PMID:17971608

Abstract

摘要

相似文献

Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands?

J Clin Oncol. 2007 Nov 1;25(31):5038-9; author reply 5039-40. doi: 10.1200/JCO.2007.13.7281.

Postmenopausal hormone therapy and breast cancer.绝经后激素治疗与乳腺癌

Prescrire Int. 2009 Apr;18(100):66-7.

[Hormone replacement therapy and breast cancer].

Med Monatsschr Pharm. 2002 Oct;25(10):337-47.

[Present status concerning hormone replacement therapy in menopause and the risk of breast cancer].

J Gynecol Obstet Biol Reprod (Paris). 1998 Oct;27(1 Suppl):12-6.

Estrogen replacement therapy and breast cancer.

J Reprod Med. 1993 Mar;38(3):183-5.

[Hormone replacement therapy in postmenopausal women and breast cancer risk: impact of estrogens deprivation and timing hypothesis].

Gynecol Obstet Fertil. 2007 Nov;35(11):1092-4. doi: 10.1016/j.gyobfe.2007.09.003. Epub 2007 Nov 8.

[Does menopausal hormonal replacement therapy increase the risk of breast cancer?].[绝经后激素替代疗法会增加患乳腺癌的风险吗？]

Duodecim. 1996;112(12):1110-5.

[Alarming data on the risk of breast cancer following estrogen replacement therapy should be interpreted carefully].

Lakartidningen. 2005;102(16):1217-8.

[Increased risk of breast cancer following hormone replacement therapy during climacteric. 3 440 extra cases might have been caused by the treatment in Sweden during the 1990s].更年期激素替代疗法后乳腺癌风险增加。20世纪90年代瑞典的该疗法可能导致了额外3440例病例。

Lakartidningen. 2005;102(16):1228-30.

[The taking of sex hormone preparations and the risk of developing breast cancer].[服用性激素制剂与患乳腺癌的风险]

Vopr Onkol. 1992;38(8):899-909.

引用本文的文献

Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017.1989 年至 2017 年荷兰按年龄、分期和受体亚型分层的首次原发性浸润性乳腺癌发病、治疗、生存和死亡率的综合趋势。

Int J Cancer. 2021 May 1;148(9):2289-2303. doi: 10.1002/ijc.33417. Epub 2020 Dec 16.

Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.荷兰乳腺钼靶筛查的有效性及过度诊断：基于人群的研究

BMJ. 2017 Dec 5;359:j5224. doi: 10.1136/bmj.j5224.

Global burden of cancer attributable to high body-mass index in 2012: a population-based study.2012 年归因于高身体质量指数的癌症全球负担：基于人群的研究。

Lancet Oncol. 2015 Jan;16(1):36-46. doi: 10.1016/S1470-2045(14)71123-4. Epub 2014 Nov 26.

Postmenopausal hormone therapy: an Endocrine Society scientific statement.绝经后激素治疗：内分泌学会科学声明。

J Clin Endocrinol Metab. 2010 Jul;95(7 Suppl 1):s1-s66. doi: 10.1210/jc.2009-2509. Epub 2010 Jun 21.

Recent changes in breast cancer incidence in Spain, 1980-2004.1980 - 2004年西班牙乳腺癌发病率的近期变化

J Natl Cancer Inst. 2009 Nov 18;101(22):1584-91. doi: 10.1093/jnci/djp358. Epub 2009 Oct 26.

The decline in breast cancer incidence: real or imaginary?乳腺癌发病率的下降：是真实的还是虚构的？

Curr Oncol Rep. 2009 Jan;11(1):21-8. doi: 10.1007/s11912-009-0005-7.

[Preclinical studies on the influence of the tyrosine kinase inhibitor AEE788 on malignant properties of renal cell carcinoma cells].酪氨酸激酶抑制剂AEE788对肾癌细胞恶性特性影响的临床前研究

Urologe A. 2008 Sep;47(9):1175-81. doi: 10.1007/s00120-008-1831-1.

Current awareness: pharmacoepidemiology and drug safety.当前动态：药物流行病学与药物安全

Pharmacoepidemiol Drug Saf. 2008 Jun;17(6):i-xvi. doi: 10.1002/pds.1487.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验